MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) notes that, as part of its active portfolio management approach, it has lodged a notice with the TSX Venture Exchange stating its intention to divest up to 5 million of its 53.333 million shares held in Harvest One Cannabis Inc. (CVE:HVT).
The Hydroponics Company Ltd (ASX:THC) (OTCMKTS:HDRPF) provides the Company's latest Investor Update Presentation.
As announced by MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) on 5 October 2018, MMJ's shareholders have approved the resolutions necessary for the disposal of PhytoTech Therapeutics Ltd to Harvest One Cannabis Inc (CVE:HVT).
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to invite shareholders to hear its CEO Jason Conroy present at Proactive Investors' CEO Spotlight Investor Session in Sydney on Monday, 22 October 2018. MMJ will be one of five companies presenting on the day and a light lunch will be provided.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a release from MediPharm Labs Inc (TSX-V: LABS) announcing that it has entered into a Cannabis Concentrate Program Agreement with Emerald Health Therapeutics Inc (CVE:EMH).
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its soon to be wholly owned subsidiary, Medcan Australia, has secured a Medical Cannabis Manufacture Licence under the ODC.
Anatara Lifesciences (ASX:ANR) is pleased to release its Annual Report, for the year ended 30th June 2018.
